Navigation Links
New data show patients using avonex reported less sick leave and short-term disability costs
Date:6/2/2008

Denver, CO June 2, 2008 Results from an analysis assessing the differences in health benefits costs (HBCs) and lost time among employees suffering from multiple sclerosis (MS) being treated with injectable disease modifying therapies (DMTs) were presented and announced by Biogen Idec as poster presentations at the Consortium of Multiple Sclerosis Center (CMSC) annual meeting in Denver, Colorado, May 28-May 31, 2008. The results revealed that patients treated with AVONEX (interferon beta-1a IM) reported significantly less sick leave, sick leave costs and short-term disability costs than patients treated with Copaxone (glatiramer acetate).

"It is clear that a key priority in the treatment of MS is for patients to maintain a sense of normalcy," said Richard Brook, Head, Retrospective Analysis, JeSTARx Group and a study author. "Data from this study show that patients taking AVONEX miss less work due to sick leave compared to patients taking Copaxone, helping to maintain their lifestyle. Also, patients taking AVONEX saved sick leave costs and short-term disability costs for their employers and healthcare insurers compared to Copaxone."

The study analyzed an integrated employer dataset of U.S. employees from 2001-2007 to gather HBCs and lost work time from the Human Capital Management Services (HCMS) Research Reference database. HCMS receives information on all employees' short- and long-term-disability claims, workers' compensation claims, and sick-leave claims (both time and salary replacement costs). The database also contains employee-specific information on demographics, company type, job type, employment status, salary, co-pays, deductibles, and health plan. The HCMS database is representative of the general U.S. workforce in terms of age and gender; however the salaries tended to be higher than the general U.S. workforce. This study included only MS patients that were employed at the time of analysis.

The HBC portion of the study
'/>"/>

Contact: Kathleen Vigneault
kathleen.vigneault@mslpr.com
617-937-2546
Manning Selvage & Lee
Source:Eurekalert

1

GOOD

Page: 1 2

Related medicine news :

1. IDM Pharma Announces Data Supporting Improved Overall Survival Advantage in Newly Diagnosed Patients with Metastatic Osteosarcoma Treated with Mifamurtide (L-MTP-PE)
2. First study to examine vitamin D insufficiency in pediatric patients with low bone density
3. Erbitux Works Well for Two-Thirds of Colon Cancer Patients
4. Anemia Drugs May Speed Tumor Growth in Some Cancer Patients
5. New combination therapy safe, promising for melanoma patients
6. Cell-Mediated Immunity and Anti-HLA Antibody Tests Provide Insight to Immune Response in Renal Transplant Patients
7. Acupuncture reduces pain and dysfunction in head and neck cancer patients after neck dissection
8. Drug may prolong organ life in noncompliant kidney transplant patients
9. Prevalence of pre-cancerous masses in the colon same in patients in their 40s and 50s
10. Black patients with terminal cancer more likely to choose aggressive care at end of life
11. Study suggests chemotherapy diminishes fertility in breast cancer patients

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)...AKLAND, Calif., Dec. 4 Herpes zost...ldren who have been vaccinated against chicken pox...cember issue of the Pediatric Infectious Diseases...d, used electronic health records to identify more...la (chicken pox) vaccine from 2002 to 2008 in Kais...
(Date:12/3/2009)...THBRIDGE, Mass., Dec. 3 The Canc...reat its first patients, Harrington Hospital annou...nts immediately," said Diane Becquart, Director of...al was granted today by the Massachusetts Departme... review of the facility. ,, The opening of The...
(Date:12/3/2009)...HICAGO, Dec. 3 The Amer...t the United States District Court for the Souther...roval of the previously disclosed $350 million set...against UnitedHealth Group. ,, The action broug... York and Missouri State Medical Association, alon...
(Date:12/3/2009)...erforms widely used sulfonylureas, but each patien...RSDAY, Dec. 3 (HealthDay News) -- A class of drug...abetes is associated with a higher risk of dying a...n, researchers say. , , Sulfonylureas, long a m... than metformin in a study of oral anti-diabetes d...
(Date:12/3/2009)... Evaluation and Treatment Clinics Also ...Vocus) December 3, 2009 -- Centegra Health System ...1 vaccine shots at four Centegra Primary Care (CPC...vaccine has arrived. The clinics are at CPC sites ...d will be open as follows: ,   From 4:3...
Breaking Medicine News(10 mins):Health News:Chicken Pox Vaccine May Also Reduce Risk of Shingles Among Children 2Health News:Chicken Pox Vaccine May Also Reduce Risk of Shingles Among Children 3Health News:Cancer Center at Harrington to Begin Seeing Patients 2Health News:Cancer Center at Harrington to Begin Seeing Patients 3Health News:Settlement in AMA Lawsuit against UnitedHealth Gets Preliminary Approval from Federal Court 2Health News:Diabetes Drugs Go Head-to-Head in Study 2Health News:Diabetes Drugs Go Head-to-Head in Study 3Health News:Centegra H1N1 Vaccination Clinics Continue 2Health News:Centegra H1N1 Vaccination Clinics Continue 3Health News:Centegra H1N1 Vaccination Clinics Continue 4
...up of fertility specialists marks its 25th anniver...challenged by economic downturn , , SAN RAMON, Ca...ration, one of the nation,s first fertility clinic...omic climate nationwide. , , Established just two...
... Feb. 16 AlphaVax announced today that it has h...ory, Quality and Clinical Operations. In this capa...rection in the areas of regulatory and quality aff...y approval for clinical trials will complement our...
...but not replace, standard screening, they say , ...ould supplement and enhance current screening and ...itute for it, according to newly released physicia...t MRI, a relatively new clinical tool. , "Health ...
...vironmental Tectonics Corporation (NYSE ALTERNEXT ...ced that on February 11, 2009, it received a lette... American Stock Exchange, stating that the Company...al basis. , , The non-compliance with Section 704...
...often deserving 2009 SSI Disability cases will not...e of mistakes made on the disability application. ...iates advise disabled consumers to take additional...ll help ensure your 2009 SSI Disability applicatio...
...09)P&G Beauty & Grooming scientists are presenting.... 12-16) that offers evidence of science,s role in...his year,s meeting theme observes the 200th annive... feel and look their best. Five studies--with subj...
Other Medicine News:Health News:Bay Area Fertility Clinic to Offer Special Help During Recession 2Health News:AlphaVax Announces New Vice President of Regulatory, Quality and Clinical Operations 2Health News:Experts Release Guidelines on Use of Breast MRI 2Health News:Environmental Tectonics Corporation Reports Receipt of Non-Compliance Notice from NYSE Alternext US LLC 2Health News:Environmental Tectonics Corporation Reports Receipt of Non-Compliance Notice from NYSE Alternext US LLC 3Health News:SSI Disability Application Tips for 2009 2Health News:SSI Disability Application Tips for 2009 3Health News:SSI Disability Application Tips for 2009 4Health News:SSI Disability Application Tips for 2009 5Health News:Beauty and grooming science evolves 2Health News:Beauty and grooming science evolves 3
(Date:12/3/2009)....C., Dec. 3 In response...nformation technologies in the evolving healthcare...ke Center for Health Informatics (DCHI) to provide...oversee an innovative interdisciplinary approach t...physicians, nurses and healthcare administrators w...
(Date:12/3/2009)...O, Dec. 3 Cardium Therap... wholly-owned subsidiary, Tissue Repair Company, s...th the U.S. Food and Drug Administration (FDA) see...roduct candidate based on positive data from the C...al study. Today,s submission with the FDA covers ...
(Date:12/3/2009)...inn., Dec. 3 Apnex Medical, Inc., ...t has completed a second round of private equity f...sed to complete a clinical study and develop a sec...nology designed to treat obstructive sleep apnea (...Domain Associates, New Enterprise Associates (NEA)...
Breaking Medicine Technology:Duke Medicine to Train Healthcare Professionals in Health Informatics 2Duke Medicine to Train Healthcare Professionals in Health Informatics 3Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds 2Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds 3Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds 4Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds 5Apnex Medical, Inc. Raises Additional $14 Million 2Apnex Medical, Inc. Raises Additional $14 Million 3This Fathers Day Give Dad a Gift Straight for the Heart 49181 1This Fathers Day Give Dad a Gift Straight for the Heart 49181 2This Fathers Day Give Dad a Gift Straight for the Heart 49181 3URAC Stresses Importance of Standards for Wellness Programs and Health Plan at AHIP Institute 2009 49179 1URAC Stresses Importance of Standards for Wellness Programs and Health Plan at AHIP Institute 2009 49179 2URAC Stresses Importance of Standards for Wellness Programs and Health Plan at AHIP Institute 2009 49179 3China Biotics Inc to Join Russell 3000 Index 12669 1China Biotics Inc to Join Russell 3000 Index 12669 2China Biotics Inc to Join Russell 3000 Index 12669 3
... Volunteers to be Presented at ...harmaceuticals,Inc. (Nasdaq: ANDS ) announced tod... of ANA598 in healthy volunteers and finalization ...patients chronically infected,with hepatitis C vir...as,well tolerated at all doses analyzed to date an...
...ASE: BIOV) from Rehovot, Israel, reported today re...vasive diagnostic test under development for,early...of 76 sputum samples were collected from four,grou...er smoked 2. Heavy smokers with no signs of lung ... 1) 4. Advanced stage lung cancer patients, The ...
Other Medicine Technology:Anadys Pharmaceuticals Announces Successful Outcome of ANA598 Healthy Volunteer Study and Finalization of Study Design for Phase Ib Trial in HCV Patients 2Anadys Pharmaceuticals Announces Successful Outcome of ANA598 Healthy Volunteer Study and Finalization of Study Design for Phase Ib Trial in HCV Patients 3Anadys Pharmaceuticals Announces Successful Outcome of ANA598 Healthy Volunteer Study and Finalization of Study Design for Phase Ib Trial in HCV Patients 4Anadys Pharmaceuticals Announces Successful Outcome of ANA598 Healthy Volunteer Study and Finalization of Study Design for Phase Ib Trial in HCV Patients 5Anadys Pharmaceuticals Announces Successful Outcome of ANA598 Healthy Volunteer Study and Finalization of Study Design for Phase Ib Trial in HCV Patients 6BioView Reports Interim Results of Early Detection Lung Cancer Diagnostic Test 2
...-dione) is a C21 steroid hormone containing a keto...d C-5 (?4).,This steroid hormone is a female sex...ulates,the accessory organs during the menstrual...ng the,endometrium for the implantation of the b...
...ACE), also known as Kininase II, is a dipeptidyl c...ght of at least 129,000. The structure of this gly...saccharide residue and a zinc atom. ACE is present...ls and renal proximal tubular cells, but is mostly...
Vitamin B6 Jumbo REA Vitamin Assays, Cardiovascular 001-RK-VB6N
Troponin I EIA Hypertension/ Cardiac Evaluation 025-BC-1105
Medicine Products: